Hamprecht K, Steinmassl M, Einsele H, Jahn G
Department of Medical Virology and Epidemiology of Viral Diseases, Unversity of Tübingen, Germany.
J Clin Virol. 1998 Aug 20;11(2):125-36. doi: 10.1016/s1386-6532(98)00046-4.
There exist only few data about the HCMV infection of single positive leukocyte subtypes in immunosuppressed patients. Most reports describe HCMV coinfection of cells of the myelomonocytic line or even T- and B-cell populations. Correlation of positive PCR findings from two major leukocyte fractions and plasma to viremia and HCMV infection in general should contribute to select suitable sources of HCMV DNA for diagnostic purposes.
The diagnostic value of qualitative leukoDNAemia of simultaneously isolated peripheral blood mononuclear cells (PBMC), granulocytes as well as plasmaDNAemia was evaluated by comparing the positive results of nested PCR from blood with virus isolation either from leukocytes or from any other sources, with serology and the clinical status of immunosuppressed patients.
PBMC, granulocytes and plasma were prepared of a total of 220 blood samples of 75 immunosuppressed patients with clinically suspected primary or recurrent HCMV infection. In a collective of 35 patients consisting mainly of recipients of marrow or solid organ transplants positive results of leuko- or plasmaDNAemia were correlated with data from HCMV screening and the clinical status. For standardization, HCMV IE Exon 4 DNA was amplified from 100 ng cellular DNA of each leukocyte population. Cross contamination can be excluded. DNA from plasma was extracted by phenol/chloroform. Using this experimental design, HCMV DNA was not detectable in PBMC, granulocytes and plasma of 23 healthy HCMV seropositive blood donors.
Leukocyte separation in a collective of 30 patients with positive leukoDNAemia revealed in only 12 cases (40%) double infection of PBMC and granulocytes. In the majority of cases (18 patients, 60%) however, HCMV DNA was detectable in only one leukocyte fraction, either in PBMC or granulocytes. LeukoDNAemia did not correlate to viremia. HCMV DNA amplified from plasma was shown to be cell free. Infectious virus from plasma was not isolated. The predictive value of qualitative nested PCR from blood to detect HCMV infection was high for plasma and decreased in the following sequence: plasma (0.92) > PBMC (0.83) > granulocytes (0.65).
Qualitative nPCR from plasma and PBMC seems to be sufficient to detect (an ongoing) HCMV infection of immunosuppressed patients. However, the rate of single positive leukocyte fractions is approximately 60%. Therefore, viral leukoDNAemia in 40% of cases seems to be restricted to either PBMC or granulocytes. For diagnostic purposes the whole leukocyte population should be used for PCR analysis.
关于免疫抑制患者单个阳性白细胞亚群的人巨细胞病毒(HCMV)感染的数据很少。大多数报告描述的是髓单核细胞系细胞甚至T细胞和B细胞群体的HCMV合并感染。来自两个主要白细胞组分和血浆的阳性PCR结果与病毒血症及一般HCMV感染之间的相关性,应有助于选择适合诊断目的的HCMV DNA来源。
通过比较血液巢式PCR的阳性结果与白细胞或其他来源的病毒分离结果、血清学及免疫抑制患者的临床状况,评估同时分离的外周血单个核细胞(PBMC)、粒细胞的定性白细胞DNA血症以及血浆DNA血症的诊断价值。
从75例临床疑似原发性或复发性HCMV感染的免疫抑制患者的220份血液样本中制备PBMC、粒细胞和血浆。在主要由骨髓或实体器官移植受者组成的35例患者群体中,白细胞或血浆DNA血症的阳性结果与HCMV筛查数据及临床状况相关。为进行标准化,从每个白细胞群体的100 ng细胞DNA中扩增HCMV IE外显子4 DNA。可排除交叉污染。血浆DNA用苯酚/氯仿提取。采用该实验设计,在23名健康的HCMV血清阳性献血者的PBMC、粒细胞和血浆中未检测到HCMV DNA。
在30例白细胞DNA血症阳性患者群体中进行白细胞分离,仅在12例(40%)中发现PBMC和粒细胞双重感染。然而,在大多数病例(18例,60%)中,仅在一个白细胞组分中可检测到HCMV DNA,要么在PBMC中,要么在粒细胞中。白细胞DNA血症与病毒血症无关。从血浆中扩增的HCMV DNA显示为游离细胞。未从血浆中分离出感染性病毒。血液定性巢式PCR检测HCMV感染对血浆的预测价值高,按以下顺序降低:血浆(0.92)>PBMC(0.83)>粒细胞(0.65)。
血浆和PBMC的定性巢式PCR似乎足以检测免疫抑制患者(正在进行的)HCMV感染。然而,单个阳性白细胞组分的比例约为60%。因此,40%病例中的病毒白细胞DNA血症似乎仅限于PBMC或粒细胞。为诊断目的,应使用整个白细胞群体进行PCR分析。